Company Filing History:
2 out of 636 
1 out of 203 
1 out of 832,912 Years Active: 2002-2005
Title: Innovations of Vijayakrishna K Gadi
Introduction
Vijayakrishna K Gadi is an accomplished inventor based in Birmingham, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic approaches. With a total of 3 patents to his name, Gadi's work focuses on innovative methods for delivering treatments to tumor cells and virally infected cells.
Latest Patents
One of his latest patents is titled "Recombinant bacterial cells for delivery of PNP to tumor cells." This invention provides a procaryotic host cell that is stably transformed or transfected by a vector containing a DNA sequence encoding for purine nucleoside phosphorylase or hydrolase. The transformed host cell can be utilized in combination with a purine substrate to effectively treat tumor cells and/or virally infected cells.
Another notable patent is "Human papillomavirus vectors for the episomal transduction of host cells and method of making same." This invention describes a replicon designed for the delivery of a transgene for episomal gene expression in a mammalian host cell. It includes a transgene with an open reading frame or other nucleic acid sequence for transcription into RNA, controlled by a surrogate promoter, along with sequences expressing essential papillomavirus proteins.
Career Highlights
Throughout his career, Gadi has worked with the UAB Research Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of gene delivery systems and their applications in medicine.
Collaborations
Gadi has collaborated with notable professionals in his field, including Eric J Sorscher and William B Parker. These collaborations have further enriched his research and innovation efforts.
Conclusion
Vijayakrishna K Gadi's contributions to biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches continue to pave the way for new therapeutic strategies.